Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation-Reference-Cited by-同舟云学术

Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation

Published:2013-02 Issue:2 Volume:21 Page:338-347
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Gujar Shashi,Dielschneider Rebecca,Clements Derek,Helson Erin,Shmulevitz Maya,Marcato Paola,Pan Da,Pan Lu-zhe,Ahn Dae-Gyun,Alawadhi Abdulaziz,Lee Patrick WK

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference36 articles.

1. Cellular immunotherapy for ovarian cancer;Cannon;Expert Opin Biol Ther,2009

2. The impact of T-cell immunity on ovarian cancer outcomes;Nelson;Immunol Rev,2008

3. A phase 3 trial of bevacizumab in ovarian cancer;Perren;N Engl J Med,2011

4. Regulatory T cells in ovarian cancer: biology and therapeutic potential;Barnett;Am J Reprod Immunol,2005

5. Immune therapy for ovarian cancer: promise and pitfalls;Thibodeaux;Int Rev Immunol,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy;Frontiers in Immunology;2024-06-07

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis;Med;2024-04

4. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation;Cancer Gene Therapy;2024-02-13

5. Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment;Molecular Therapy - Oncolytics;2023-12